Clinical trial
Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for…
NCT00153192 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00153192 |
|---|---|
| Title | Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain |
| Official title | A Randomized Controlled Clinical Trial of Dronabinol (Marinol) vs Placebo as Add-on Therapy For Patients on Opioids for Chronic Pain |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Pain |
| Intervention type | Drug |
| Interventions | Marinol (dronabinol) |
| Enrollment | 30 |
| Start date | Apr 1, 2001 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: